ID: ALA157927

Max Phase: Preclinical

Molecular Formula: C11H10N4O3

Molecular Weight: 246.23

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(Nc2nc(O)nc(O)c2N=O)cc1

Standard InChI:  InChI=1S/C11H10N4O3/c1-6-2-4-7(5-3-6)12-9-8(15-18)10(16)14-11(17)13-9/h2-5H,1H3,(H3,12,13,14,16,17)

Standard InChI Key:  KISQMZNLGUJUJL-UHFFFAOYSA-N

Associated Targets(non-human)

DNA topoisomerase III 145 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 246.23Molecular Weight (Monoisotopic): 246.0753AlogP: 2.34#Rotatable Bonds: 3
Polar Surface Area: 107.70Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.63CX Basic pKa: CX LogP: 4.64CX LogD: 4.64
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.72Np Likeness Score: -0.95

References

1. Trantolo DJ, Wright GE, Brown NC..  (1986)  Inhibitors of Bacillus subtilis DNA polymerase III. Influence of modifications in the pyrimidine ring of anilino- and (benzylamino)pyrimidines.,  29  (5): [PMID:3084785] [10.1021/jm00155a016]

Source